- Trials with a EudraCT protocol (394)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
394 result(s) found for: pharmacogenetics.
Displaying page 1 of 20.
| EudraCT Number: 2017-005100-99 | Sponsor Protocol Number: TYH2018307 | Start Date*: 2018-06-14 |
| Sponsor Name:Helsinki University and University Hospital | ||
| Full Title: Pharmacoepidemiology and pharmacogenetics of antidepressant treatment for depressive disorders (PEGAD) | ||
| Medical condition: Depression (ICD-10 F32 and F33). Clinically diagnosed depression (F32-33), with symptom severity equaling or exceeding score 10 in the Patient Health Questionnaire (PHQ-9) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-003945-41 | Sponsor Protocol Number: N/A | Start Date*: 2005-02-15 |
| Sponsor Name:liverpool university | ||
| Full Title: Pharmacogenetics of GABAergic mechanisms of benefit and harm in epilepsy: : A prospective cohort study to determine the enviromental and genetic factors associated with response to clobazam. | ||
| Medical condition: Epilepsy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023189-27 | Sponsor Protocol Number: RG-10-179 | Start Date*: 2011-01-20 |
| Sponsor Name:University of Birmingham | ||
| Full Title: The pharmacogenetics of vitamin D response in tuberculosis | ||
| Medical condition: Tuberculosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001232-42 | Sponsor Protocol Number: RGHT000270 | Start Date*: 2006-06-14 |
| Sponsor Name:Royal Group of Hospitals Trust | ||
| Full Title: The Pharmacogenetics of Aspirin Resistance | ||
| Medical condition: Aspirin resistance: Vascular diseases are common problems and aspirin is used as an anti-platelet drug to prevent thrombosis. However, aspirin's anti-platelet effect may not be uniform in all patie... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002686-36 | Sponsor Protocol Number: 20053 | Start Date*: 2005-09-19 |
| Sponsor Name:Všeobecná fakultní nemocnice v Praze | ||
| Full Title: Developmental pharmacokinetics and pharmacogenetics aspects of analgosedation by tramadol of newborns, infants and older children treated at the intensive care unit | ||
| Medical condition: children requiring analgosedation with tramadol | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001176-10 | Sponsor Protocol Number: CNTO136ARA3004 | Start Date*: 2013-09-09 | |||||||||||
| Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
| Full Title: A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNT... | |||||||||||||
| Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: LT (Completed) ES (Completed) IT (Completed) DE (Prematurely Ended) PT (Completed) AT (Completed) GB (Completed) BE (Completed) NL (Completed) PL (Completed) HR (Completed) BG (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-003947-51 | Sponsor Protocol Number: M14POS | Start Date*: 2014-10-06 | |||||||||||
| Sponsor Name:NKI-AVL | |||||||||||||
| Full Title: Phase I/prospective randomized phase II trial Of the Safety and Efficacy of tamoxifen in combination with the Isoform selective Pi3K inhibitor GDC-0032 compared with tamoxifen alONe in hormone rece... | |||||||||||||
| Medical condition: Hormone receptor positive metastatic breast cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: GB (Temporarily Halted) NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-013022-16 | Sponsor Protocol Number: ZonMw 80-82100-98-096/11510014 | Start Date*: 2009-10-21 | |||||||||||
| Sponsor Name:Erasmus MC [...] | |||||||||||||
| Full Title: Effecten en bijwerkingen van opioïden: een studie naar de rol van farmacokinetische en farmacogenetische heterogeniteit. | |||||||||||||
| Medical condition: Nociceptive cancer pain for which strong opioids are needed | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-003731-31 | Sponsor Protocol Number: 2005 PK 02 | Start Date*: 2005-03-09 |
| Sponsor Name:University Hospitals of Leiceter NHS Trust | ||
| Full Title: Pharmacogenetics and metabolism of cyclophosphamide in paediatric non-Hodgkin’s Lymphoma | ||
| Medical condition: non-Hodgkin's Lymphoma | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-007319-33 | Sponsor Protocol Number: OP08/8679 | Start Date*: 2009-02-19 |
| Sponsor Name:Leeds Teaching Hospitals NHS Trust | ||
| Full Title: Do genes predict response to treatment in age-related macular degeneration? | ||
| Medical condition: Choroidal neovascularisation secondary to age-related macular degeneration (ARMD) | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004082-42 | Sponsor Protocol Number: OXY-2 | Start Date*: 2005-12-05 |
| Sponsor Name:Søren Sindrup, Dept. of Neurology, University Hospital of Odense | ||
| Full Title: The Pharmacogenetics of Oxycodone analgesia in human experimental pain models | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-001014-37 | Sponsor Protocol Number: ALTUM | Start Date*: 2020-08-13 | ||||||||||||||||
| Sponsor Name:OSPEDALE SAN RAFFAELE | ||||||||||||||||||
| Full Title: Pharmacogenetics of hypertension: randomized monocentric study in patients with essential hypertension and treated with Spironolactone or Torasemide | ||||||||||||||||||
| Medical condition: Essential hypertension | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: IT (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2005-001895-11 | Sponsor Protocol Number: AI424-138 | Start Date*: 2006-02-07 |
| Sponsor Name:Bristol-Myers Squibb International Corporation | ||
| Full Title: A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment... | ||
| Medical condition: HIV-1 Infected Treatment Naive Subjects | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) DE (Completed) AT (Completed) BE (Completed) PT (Completed) ES (Completed) DK (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001641-89 | Sponsor Protocol Number: PM1183-C-003-14 | Start Date*: 2016-06-28 | |||||||||||
| Sponsor Name:Pharma Mar S.A. | |||||||||||||
| Full Title: Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients w... | |||||||||||||
| Medical condition: Small-Cell Lung Cancer (SCLC) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) AT (Completed) BE (Completed) ES (Completed) DE (Completed) GR (Completed) PT (Completed) CZ (Completed) NL (Completed) BG (Completed) GB (Completed) PL (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-006413-33 | Sponsor Protocol Number: 3206K2-104-WW | Start Date*: 2008-02-14 |
| Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc | ||
| Full Title: A Phase 1/2 Dose Escalation Study of TRU-015 in Subjects with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | ||
| Medical condition: Relapsed or refractory B-cell Non Hodgkin's Lymphoma. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-003425-81 | Sponsor Protocol Number: RLBUHT2763 | Start Date*: 2007-03-29 |
| Sponsor Name:University of Liverpool | ||
| Full Title: Host genetic factors influencing drug disposition and response to HIV treatment | ||
| Medical condition: Pharmacogeneric study of HIV+ patients receiving antiretroviral therapy. We wish to correlate drug concentration with host genetic patients receiving certain HIV drugs. No dosage modification will... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002845-36 | Sponsor Protocol Number: PK200609 | Start Date*: 2006-11-14 |
| Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
| Full Title: Pharmacokinetics and pharmacogenetics of anticancer drugs in infants and young children | ||
| Medical condition: Any childhood cancer. | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-019423-61 | Sponsor Protocol Number: GENRAS | Start Date*: 2010-10-28 |
| Sponsor Name:Medizinische Universität Wien,Univ.Klinik f.Psychiatrie und Psychotherapie | ||
| Full Title: GENRAS (GENetics of Response to Agomelatine vs. EScitalopram) | ||
| Medical condition: depressive disorder | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001905-66 | Sponsor Protocol Number: BA-SCAD | Start Date*: 2021-07-06 |
| Sponsor Name:Spanish Cardiology Society | ||
| Full Title: Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissection | ||
| Medical condition: Spontaneous Coronary Artery Dissection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002754-62 | Sponsor Protocol Number: 2004-001 | Start Date*: 2006-06-20 |
| Sponsor Name:University of Göttingen; Dep. of Clinical Pharmacology | ||
| Full Title: Development of CYP2D6 genotype based dosage guidelines for the beta-blockers metoprolol and carvedilol based on hepatic clearance and resting and exercise heart rate reduction | ||
| Medical condition: Healthy male and female volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
